Compare HUYA & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HUYA | CTKB |
|---|---|---|
| Founded | 2014 | 1990 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 572.2M | 541.1M |
| IPO Year | 2018 | 2021 |
| Metric | HUYA | CTKB |
|---|---|---|
| Price | $2.37 | $4.51 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 4 |
| Target Price | $3.50 | ★ $5.63 |
| AVG Volume (30 Days) | 724.3K | ★ 2.1M |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | ★ 81.37% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $193,015,000.00 |
| Revenue This Year | $14.08 | $5.42 |
| Revenue Next Year | $6.11 | $7.03 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 17.67 |
| 52 Week Low | $2.15 | $3.22 |
| 52 Week High | $4.93 | $6.18 |
| Indicator | HUYA | CTKB |
|---|---|---|
| Relative Strength Index (RSI) | 44.85 | 53.51 |
| Support Level | $2.15 | $4.17 |
| Resistance Level | $2.53 | $4.78 |
| Average True Range (ATR) | 0.07 | 0.19 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 15.79 | 42.27 |
Huya officially became independent in 2016 and is headquartered in Guangzhou. It operates a live streaming platform focused on games, esports, and interactive entertainment, and also provides game-related services such as distribution and in-game item sales. Its main livestreaming platforms include Huya Live in China and Nimo TV outside of China. Huya is a subsidiary of Tencent, which owned 67% of its equity stake and held 95% of the voting power, as of the end of 2025.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.